TriLink, Astral Scientific Forge Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a distribution deal covering Australia with Astral Scientific for its nucleic acid products.

Products covered by the deal include more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products, San Diego-based TriLink said.

Financial terms of the deal were not disclosed.

Astral supplies core consumables to the clinical diagnostic, life science, and industrial markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.